Registry of Patients Living With Type 1 Diabetes

NCT03720197 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2025-02-25

No results posted yet for this study

Summary

A registry of individuals with type 1 diabetes open to all patients with type 1 diabetes living in Canada will be established. The objective of this registry will be to measure the frequency and the severity of episodes of hypoglycemia. Participants will be invited to answer questionnaires about the frequency of their hypoglycemic episodes, their fear about hypoglycemia, their symptoms of hypoglycemia, the factors in cause (insulin therapy, nutrition, exercise, etc.), etc.

Participation to the registry is divided in 3 phases. The first phase is mandatory for all participants. Phases 2 and 3 are optional.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

OTHER

Online questionnaire - Phase 1

Draw an overall picture of the population with type 1 diabetes in Canada in terms of demographics, diabetes treatment, hypoglycemia frequency and diabetes complications.

OTHER

Online questionnaire - Phase 2

Characterize the causes, experience and consequences of hypoglycemia.

OTHER

Online questionnaire - Phase 3

Collect information on diabetes and hypoglycemia treatment, hyperglycemia management, sleep habits, depression, physical activity and the benefits of technologies to reduce the frequency of hypoglycemia.

OTHER

Food questionnaire

24-hour food recall questionnaire

OTHER

Pedometer

Participants will wear a podometer for 14 consecutives days

OTHER

Waist circumference

Participants will be asked to measure their waist circumference

OTHER

Blood and urine tests

Participants will be invited to send us their latests blood and urine test results.

OTHER

List of medications

Participants will be invited to send us their list of medications

OTHER

Continuous glucose monitor

Participants will be invited to send us the latest report of their continuous glucose monitor

Sponsors & Collaborators

  • Institut de Recherches Cliniques de Montreal

    lead OTHER

Principal Investigators

  • Remi Rabasa-Lhoret · Institut de recherches cliniques de Montréal

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-20
Primary Completion
2027-03-31
Completion
2027-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03720197 on ClinicalTrials.gov